Latest News and Press Releases

AVITA Medical reports fourth quarter and full-year 2023 financial results.

AVITA Medical to announce fourth quarter and full year 2023 financial results on February 22, 2024, at 1:30 p.m. Pacific Time.

AVITA Medical announced exclusive multi-year distribution agreement with Stedical Scientific, Inc. to commercialize PermeaDerm in the United States.

AVITA Medical announced preliminary unaudited financial highlights for the fourth quarter 2023, 2024 financial guidance, and full enrollment of TONE.

AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.

AVITA Medical to host investor webinar briefing on December 5, 2023, at 2:00 p.m. PST. Register at https://rebrand.ly/Dec2023webinar

VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...

VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...

VALENCIA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...

AVITA Medical announced it has entered into a distribution agreement with PolyMedics Innovations, to strategically expand its global presence to Europe.